- Home
- PVLA vs ECVT Comparison
PVLA vs ECVT Comparison
Compare PVLA & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | ECVT |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | PVLA | ECVT |
|---|---|---|
| Price | $129.95 | $14.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $171.87 | $14.00 |
| AVG Volume (30 Days) | 228.3K | ★ 2.7M |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $723,515,000.00 |
| Revenue This Year | N/A | $26.96 |
| Revenue Next Year | $102,383.52 | $5.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $20.20 | $5.68 |
| 52 Week High | $151.18 | $14.43 |
Technical Indicators
Market Signals| Indicator | PVLA | ECVT |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 70.37 |
| Support Level | $108.99 | $12.74 |
| Resistance Level | $133.06 | N/A |
| Average True Range (ATR) | 9.01 | 0.46 |
| MACD | 0.64 | 0.09 |
| Stochastic Oscillator | 83.37 | 76.80 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.